InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Keenan Greg. Director active across 1 company, notably Aurinia Pharmaceuticals Inc.. Aggregated, 6 reports have been logged. Split: 0 buy · 2 sells. Total volume traded: €247k. Activity tracked since 28 February 2025. The latest transaction was filed on 6 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Keenan Greg is a declarant linked to Aurinia Pharmaceuticals Inc. (XNAS), and the transaction volume observed in the sampled recent filings covers the period from 2025-03-04 to 2026-03-10. Across these 6 filings in total, buys are 0 EUR and sells are 247186 EUR, with Retenue fiscale as the most frequent transaction nature.